Member Info for chrishutch

This will move back up just as fast, they dipped it o nothing to try and get sellers and fill that order. There is very little stock available so if we have big buyers then they will have to pay more or move on.

On track and on plan they said

Buyers liking it by the looks

CEO delivers well, cool calm and professional

New video out

Https://rb.gy/jwgv1k Here we go

Could be great end to the week at this rate

Buyers now taking all loose stock

Swallowing sells at above bid and still looking strong, hopefully we can relax and watch it drift up over the next few sessions.

SCAP had been loading the bid, so let’s wait for auction period to see if they are still buying via smoke and mirrors - I see you.

Https://x.com/fsnantibodies/status/1823323649987826157?s=61

Has to move up really, undervalued

Someone has to take them, not much available before the jump.

Does look ready to go tho, book is strong, should climb on buys.

Not me.

Blue

Loading up ahead of news

I would think 6p is very achievable, I am hoping for more tho.

Depends on news and ability to sit tight as it climbs

There is clearly a lot more going on behind the curtain. It is about time they let Dorothy see the magic.

“In summary, three highly sensitive ELISA assays were developed by Fusion Antibodies to quantitate unphosphorylated TF, TF-Pser253 and TF-Pser258 in urine. TF-Pser258 represents a potential new urinary biomarker for bladder cancer including early disease.”

“Unphosphorylated TF is also a novel marker for advanced bladder cancer and their concurrent use may allow a nuanced approach to the diagnostics of bladder cancer from the outset.”

TF-Pser253 had a sensitivity of 71% and specificity of 69% at 0.55 ng/ml cut-off determined by ROC analysis. Suggesting that TF-Pser253 could be a promising urinary marker for early diagnosis of colon cancer.

Has to go up, this price is crazy cheap